ChartMill assigns a Buy % Consensus number of 43% to HLVX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-31 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-08-12 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-07-09 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-07-09 | Stifel | Downgrade | Buy -> Hold |
| 2024-07-09 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-07-08 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-07-08 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-05-15 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-05-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-13 | HC Wainwright & Co. | Initiate | Buy |
| 2023-11-15 | Guggenheim | Maintains | Buy -> Buy |
| 2023-11-10 | Stifel | Maintains | Buy -> Buy |
| 2023-05-16 | JP Morgan | Maintains | Overweight -> Overweight |
| 2022-05-24 | Guggenheim | Initiate | Buy |
| 2022-05-24 | SVB Leerink | Initiate | Outperform |
| 2022-05-24 | Stifel | Initiate | Buy |
| 2022-05-24 | JP Morgan | Initiate | Overweight |
6 analysts have analysed HLVX and the average price target is 2.04 USD. This implies a price decrease of -2.39% is expected in the next year compared to the current price of 2.09.
The consensus rating for HILLEVAX INC (HLVX) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.